 |
 |
|
|
RESÚMENES JULIO 2005 |
Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers
(Requiere estar conectado a internet.
Haga un click en la información del journal)
M. P. Freeman, A. J. Gelenberg
Acta Psychiatrica Scandinavica. Volume 112 Issue
2 Page 88 - August 2005
One-year outcome with antidepressant
R. T. Joffe, G. M. MacQueen, M. Marriott, L. T.
Young
Acta Psychiatrica Scandinavica. Volume 112 Issue
2 Page 105 - August 2005
E. Bora, S. Vahip, A. S. Gonul, F. Akdeniz, M.
Alkan, M. Ogut, A. Eryavuz
Acta Psychiatrica Scandinavica. Volume 112 Issue
2 Page 110 - August 2005
Adjunctive bright light in non-seasonal major depression: results from
clinician-rated depression scales
K. Martiny, M. Lunde, M. Undén, H. Dam, P. Bech
Acta Psychiatrica Scandinavica. Volume 112 Issue
2 Page 117 - August 2005
Adverse childhood experiences, stressful life events or demographic
factors: which are important in women's depression? A 2-year follow-up
population study
Kirsi Honkalampi, Jukka Hintikka, Kaisa Haatainen,
Heli Koivumaa-Honkanen, Antti Tanskanen, Heimo Viinamäki
Australian and New Zealand Journal of Psychiatry.
Volume 39 Issue 7 Page 627 - July 2005
Maria E. Fisfalen, Thomas G. Schulze, J. Raymond DePaulo Jr., Leslie J.
DeGroot, Judith A. Badner, and Francis J. McMahon
Am J Psychiatry
162:1266-1272, July 2005
Comparison of Rapid-Cycling and Non-Rapid-Cycling Bipolar Disorder Based on Prospective Mood Ratings in 539 Outpatients
Ralph W. Kupka, David A. Luckenbaugh, Robert M. Post, Trisha Suppes,
Lori L. Altshuler, Paul E. Keck Jr., Mark A. Frye, Kirk D. Denicoff, Heinz
Grunze, Gabriele S. Leverich, Susan L. McElroy, Jörg Walden, and Willem A.
Nolen
Am J Psychiatry
162:1273-1280, July 2005
Olanzapine Versus Lithium in the Maintenance Treatment of Bipolar Disorder: A 12-Month, Randomized, Double-Blind, Controlled Clinical Trial
Mauricio Tohen, Waldemar Greil, Joseph R. Calabrese, Gary S. Sachs,
Lakshmi N. Yatham, Bruno Müller Oerlinghausen, Athanasios Koukopoulos, Giovanni
B. Cassano, Heinz Grunze, Rasmus W. Licht, Liliana Dell’Osso, Angela R. Evans,
Richard Risser, Robert W. Baker, Heidi Crane, Martin R. Dossenbach, and Charles
L. Bowden
Am J Psychiatry 162:1281-1290, July 2005
A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression
Joseph R. Calabrese, Paul E. Keck Jr., Wayne Macfadden, Margaret
Minkwitz, Terence A. Ketter, Richard H. Weisler, Andrew J. Cutler, Robin McCoy,
Ellis Wilson, and Jamie Mullen, The BOLDER Study Group
Am J Psychiatry
162:1351-1360, July 2005
Generalizability of Antidepressant Efficacy Trials: Differences Between Depressed Psychiatric Outpatients Who Would or Would Not Qualify for an Efficacy Trial
Mark Zimmerman, Iwona Chelminski, and Michael A. Posternak
Am J Psychiatry 162:1370-1372, July 2005
`Bipolarity' in bipolar disorder: distribution of manic and depressive symptoms in a treated population
MARK S. BAUER, GREGORY E. SIMON, EVETTE LUDMAN, JURGEN UNÜTZER
The British Journal of Psychiatry (2005) 187: 87-88
Rapid
cycling bipolar disorder : clinical characteristics and treatment options.
Coryell W
A Placebo-Controlled, Randomized, Double-Blind Study of Adjunctive Bupropion Sustained Release in the Treatment of SSRI-Induced Sexual Dysfunction
Charles DeBattista,
Brent Solvason, Jennifer Poirier, Ellen Kendrick, and Emily Loraas
J Clin Psychiatry 2005;66:844-848
What Happens With Adverse Events During 6 Months of Treatment With Selective Serotonin Reuptake Inhibitors?
Koen Demyttenaere,
Adelin Albert, Patrick Mesters, Walthčre Dewé, Katrien De Bruyckere, and
Michčle Sangeleer
J Clin Psychiatry 2005;66:859-863
Predictors for the Efficacy of Electroconvulsive Therapy: Chart Review of a Naturalistic Study
King Han Kho,
Aeilko H. Zwinderman, and Ben A. Blansjaar
J Clin Psychiatry 2005;66:894-899
Add-On rTMS for Medication-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial in Chinese Patients
Tung-Ping Su,
Chih-Chia Huang, and I-Hua Wei
J Clin Psychiatry 2005;66:930-937
Stefano Pini,
Valéria de Queiroz, Daniel Pagnin, Lukas Pezawas, Jules Angst, Giovanni B.
Cassano and Hans-Ulrich Wittchen
European
Neuropsychopharmacology. Volume 15, Issue 4, August 2005, Pages 425-434
Size
& Burden of Mental Disorders in Europe. The epidemiology
of panic disorder and agoraphobia in Europe
R.D. Goodwin, C.
Faravelli, S. Rosi, F. Cosci, E. Truglia, R. de Graaf and H.U. Wittchen
European Neuropsychopharmacology. Volume 15, Issue 4,
August 2005, Pages 435-443
Roselind Lieb, Eni
Becker and Carlo Altamura
European Neuropsychopharmacology. Volume 15, Issue 4,
August 2005, Pages 445-452
Lydia Fehm, Antoine
Pelissolo, Tomas Furmark and Hans-Ulrich Wittchen
European
Neuropsychopharmacology. Volume 15, Issue 4, August 2005, Pages 453-462
Duloxetine
for the treatment of major depressive disorder in women ages 40 to 55 years
Burt VK, Wohlreich MM, Mallinckrodt CH, Detke MJ, Watkin JG, Stewart DE
Psychosomatics. 2005 Jul-Aug;46(4):345-54
Sleep disturbance in anxiety disorders
George N. Papadimitriou and
Paul Linkowski
International Review of Psychiatry; Volume 17, Number
4 / August 2005: 229 - 236
Heather M. Burke,
Mary C. Davis, Christian Otte and David C. Mohr
Psychoneuroendocrinology. Volume 30, Issue 9, October 2005, Pages
846-856
Francesca
Brambilla, Carmen Mellado, Alessandra Alciati, Maria Giuseppina Pisu, Robert H.
Purdy, Stefano Zanone, Giulia Perini, Mariarosa Serra and Giovanni Biggio
Psychiatry Research. Volume 135, Issue 3, 30 June 2005, Pages
185-190
Henry Brodaty, Breda Cullen, Claire Thompson, Philip Mitchell, Gordon
Parker, Kay Wilhelm, Marie-Paule Austin, and Gin Malhi
Am J Geriatr Psychiatry 13:589-596, July 2005
Mohit P. Chopra, Cynthia Zubritsky, Kathryn Knott, Thomas Ten Have,
Trevor Hadley, James C. Coyne, and David W. Oslin
Am J Geriatr Psychiatry 13:597-606, July 2005
Karen M. Goldstein, Linda H. Harpole, Karen M. Stechuchak, Cynthia J.
Coffman, Hayden B. Bosworth, David C. Steffens, and Lori A. Bastian
Am
J Geriatr Psychiatry 13:616-623, July 2005
Ziprasidone in Acute Bipolar Mania: A 21-Day Randomized, Double-Blind,
Placebo-Controlled Replication Trial
Potkin, Steven G.; Keck, Paul E. Jr; Segal,
Scott; Ice, Kathleen; English, Patricia
Journal of Clinical Psychopharmacology. 25(4):301-310,
August 2005
Sex Differences in Antidepressant Response in Recent Antidepressant
Clinical Trials
Khan, Arif; Brodhead, Amy E.; Schwartz,
Kelly A.; Kolts, Russell L.; Brown, Walter A
Journal of Clinical Psychopharmacology. 25(4):318-324,
August 2005
Drug Interactions Between Lamotrigine and Psychoactive Drugs: Evidence
From a Therapeutic Drug Monitoring Service
Reimers, Arne; Skogvoll, Eirik; Sund, Janne
Kutschera; Spigset, Olav
Journal of Clinical Psychopharmacology. 25(4):342-348,
August 2005
Neurologic Soft Signs in Schizophrenic Patients Treated With
Conventional and Atypical Antipsychotics
Bersani, Giuseppe; Gherardelli, Simona;
Clemente, Roberta; Di Giannantonio, Massimo; Grilli, Alfredo; Conti, Chiara M.
V.; Exton, Michael S.; Conti, Pio; Doyle, Robert; Pancheri, Paolo
Journal
of Clinical Psychopharmacology. 25(4):372-375, August 2005
Flexible-Dose Clinical Trials: Predictors and Outcomes of Antipsychotic
Dose Adjustments
Lipkovich, Ilya; Baron, David; Houston, John; Ahl, Jonna;
Rotelli, Matthew
Journal of Clinical
Psychopharmacology. 25(4):381-386, August 2005
The Efficacy of Antidepressants in the Treatment of Late-Life Depression
Roose, Steven P.; Schatzberg, Alan F.
Journal of Clinical
Psychopharmacology. 25 Supplement 1:S1-S7, August 2005
Trajectories of Treatment Response in Late-Life Depression: Psychosocial
and Clinical Correlates
Gildengers, Ariel G.; Houck, Patricia R.; Mulsant, Benoit
H.; Dew, Mary Amanda; Aizenstein, Howard J.; Jones, Bobby L.; Greenhouse, Joel;
Pollock, Bruce G.; Reynolds, Charles F. III
Journal of Clinical
Psychopharmacology. 25 Supplement 1:S8-S13, August 2005
Treatment of Depression in the Medically Ill
Krishnan, K. Ranga Rama
Journal of Clinical
Psychopharmacology. 25 Supplement 1:S14-S18, August 2005
Achieving Adequate Outcomes in Geriatric Depression: Standardized
Criteria for Remission
Kupfer, David J
Journal of Clinical
Psychopharmacology. 25 Supplement 1:S24-S28, August 2005
Placebo Control Groups in Trials of Major Depressive Disorder Among
Older Patients
Walsh, B. Timothy; Sysko, Robyn
Journal of Clinical
Psychopharmacology. 25 Supplement 1:S29-S33, August 2005
Optimal Length of Antidepressant Trials in Late-Life Depression
Sackeim, Harold A.; Roose, Steven P.; Burt, Tal
Journal of Clinical
Psychopharmacology. 25 Supplement 1:S34-S37, August 2005
A Comparison of Brain and Serum Pharmacokinetics of
R-Fluoxetine and Racemic Fluoxetine: A 19-F MRS Study
Michael E Henry, Mark E Schmidt,
John Hennen, Rosemond A Villafuerte, Michelle L Butman, Pierre Tran, Lynn T
Kerner, Bruce Cohen and Perry F Renshaw
Neuropsychopharmacology (2005) 30, 1576-1583
Titia A.
Spijkerman, Rob H.S. van den Brink, Jaap H.C. Jansen, Harry J.G.M. Crijns and
Johan Ormel
Journal of Psychosomatic Research. Volume 58, Issue 5,
May 2005, Pages 425-432
David
L Dunner
Bipolar Disorders. Volume 7 Issue 4 Page
307 - August 2005
Five-year
prospective outcome of psychopathology in the adolescent offspring of bipolar
parents
Manon
HJ Hillegers, Catrien G Reichart,
Marjolein Wals, Frank C Verhulst, Johan Ormel and Willem A Nolen
Bipolar Disorders. Volume 7 Issue 4 Page
344 - August 2005
Anders
F Thomsen and Lars V Kessing
Bipolar Disorders. Volume 7 Issue 4 Page
351 - August 2005
Evidence for
orbitofrontal pathology in bipolar disorder and major depression, but not in
schizophrenia
David
Cotter, Lance Hudson and Sabine Landau
Bipolar Disorders. Volume 7 Issue 4 Page
358 - August 2005
D
Deshauer, D Fergusson, A Duffy, J Albuquerque and P Grof
Bipolar Disorders. Volume 7 Issue 4 Page
382 - August 2005
Clinical application of single-pulse transcranial magnetic stimulation
for the treatment of depression
KENICHI FUJITA AND YOSHIHIKO KOGA
Psychiatry and Clinical
Neurosciences. Volume 59 Issue 4 Page 425 - August 2005
David J. Muzina, Joseph R. Calabrese
Australian and New Zealand Journal of Psychiatry.
Volume 39 Issue 8 Page 652 - August 2005
Caryl Barnes, Philip Mitchell
Australian and New Zealand Journal of Psychiatry.
Volume 39 Issue 8 Page 662 - August 2005
Pharmacotherapy for posttraumatic stress disorder: empirical review and
clinical recommendations
John Cooper, Jessica Carty, Mark Creamer
Australian and New Zealand Journal of Psychiatry.
Volume 39 Issue 8 Page 674 - August 2005
Sheila M. Marcus,
Elizabeth A. Young, Kevin B. Kerber, Susan Kornstein, Amy H. Farabaugh, Jeff
Mitchell, Stephen R. Wisniewski, G.K. Balasubramani, Madhukar H. Trivedi and A.
John Rush
Journal
of Affective Disorders. Volume 87, Issues 2-3, August 2005, Pages 141-150
First incidence
depression in the Lundby Study: A comparison of the two time periods 1947–1972
and 1972–1997
Cecilia Mattisson,
Mats Bogren, Per Nettelbladt, Povl Munk-Jörgensen and Dinesh Bhugra
Journal
of Affective Disorders. Volume 87, Issues 2-3, August 2005, Pages 151-160
Treatment of
generalized anxiety disorder with escitalopram: Pooled results from
double-blind, placebo-controlled trials
Wayne K. Goodman,
Anjana Bose and Qin Wang
Journal
of Affective Disorders. Volume 87, Issues 2-3, August 2005, Pages 161-167
G.B. Parker, G.S.
Malhi, J.G. Crawford and M.E. Thase
Journal
of Affective Disorders. Volume 87, Issues 2-3, August 2005, Pages 185-191
Topiramate in
treatment of depressive and anger symptoms in female depressive patients: A
randomized, double-blind, placebo-controlled study
Cerstin Nickel,
Claas Lahmann, Karin Tritt, Moritz Muehlbacher, Patrick Kaplan, Christian
Kettler, Jakub Krawczyk, Thomas H. Loew, Wolfhardt K. Rother and Marius K.
Nickel
Journal
of Affective Disorders. Volume 87, Issues 2-3, August 2005, Pages 243-252
Efficacy,
predictors of therapy response, and safety of sertraline in routine clinical
practice: Prospective, open-label, non-interventional postmarketing
surveillance study in 1878 patients
Bernd Löwe, Irini
Schenkel, Matthew J. Bair and Claus Göbel
Journal
of Affective Disorders. Volume 87, Issues 2-3, August 2005, Pages 271-279
Subthreshold
depression is linked to the functional polymorphism of the 5HT transporter gene
Xenia Gonda,
Gabriella Juhasz, Andras Laszik, Zoltan Rihmer and Gyorgy Bagdy
Journal
of Affective Disorders. Volume 87, Issues 2-3, August 2005, Pages 291-297
George Kirov, John
Tredget, Rhys John, Michael J. Owen and John H. Lazarus
Journal
of Affective Disorders. Volume 87, Issues 2-3, August 2005, Pages 313-317
Investigating
the effects of estradiol or estradiol/progesterone treatment on mood,
depressive symptoms, menopausal symptoms and subjective sleep quality in older
healthy hysterectomized women: a questionnaire study
Heinrich AB, Wolf OT
Neuropsychobiology. 2005;52(1):17-23. Epub 2005 Jun 3
Cerebral Blood
Flow Changes After Treatment of Social Phobia with the Neurokinin-1 Antagonist
GR205171, Citalopram, or Placebo
Tomas Furmark,
Lieuwe Appel, Ĺsa Michelgĺrd, Kurt Wahlstedt, Fredrik Ĺhs, Stefano Zancan, Eva
Jacobsson, Karin Flyckt, Magnus Grohp, Mats Bergström, Emilio Merlo Pich,
Lars-Göran Nilsson, Massimo Bani, Bengt Lĺngström and Mats Fredrikson
Biological Psychiatry. Volume 58, Issue 2, 15 July 2005, Pages
132-142
Dunner DL
Bipolar Disord 2005: 7: 307-325
Deshauer D,
Fergusson D, Duffy A, Albuquerque J, Grof P
Bipolar Disord 2005: 7: 382-387
Inter-
and Intraindividual Pharmacokinetic Variations of Mirtazapine and Its
N-Demethyl Metabolite in Patients Treated for Major Depressive Disorder: A
6-Month Therapeutic Drug Monitoring Study.
Reis M, Prochazka J, Sitsen
A, Ahlner J, Bengtsson F
Ther Drug Monit. 2005 Aug;27(4):469-477
Nine-month predictors and outcomes of SSRI antidepressant continuation in
primary care.
James E.Aikens, Kurt Kroenke, Ralph
W. Swindle, George J. Eckert
General Hospital Psychiatry. Volume 27, Issue 4, Pages
229-236 (July 2005)